the current landscape for the treatment of r/r aml in the post-transplant setting
Published 2 months ago • 110 plays • Length 6:44Download video MP4
Download video MP3
Similar videos
-
2:36
the current treatment landscape for aml
-
1:29
the current landscape of immunotherapy for aml: an update from ash 2023
-
2:14
update on the aml treatment landscape
-
1:29
the current landscape of maintenace therapy in aml and areas for future exploration
-
1:28
the role of allogeneic transplantation in patients with aml in the frontline setting
-
3:37
the future of aml treatment
-
5:09
what do you see as the future of aml treatments? #aml
-
6:39
treatment failure and relapse in acute myeloid leukemia (aml)
-
14:43
current research into post-allosct maintenance therapy in aml
-
2:42
dr juckett on the evolving treatment paradigm in relapsed/refractory aml
-
5:11
the frontline treatment strategy for newly diagnosed aml
-
1:33
sorafenib as maintenance therapy for patients with transplant-ineligible or post-allosct aml
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
2:38
session highlights: transforming aml treatment and building on new approaches
-
1:20
mimetics: the future of aml treatment?
-
6:22
post-transplant maintenance for patients with aml
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
5:25
how the aml treatment landscape is changing with the introduction of novel targeted agents
-
1:41
the future of aml and mds diagnosis and treatment
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
1:19
new treatments for aml
-
3:40
how the aml treatment landscape has evolved with the use of novel combination therapies